Back to Search Start Over

Role of NRF2 and Sirtuin activators in COVID-19.

Authors :
Khan H
Patel S
Majumdar A
Source :
Clinical immunology (Orlando, Fla.) [Clin Immunol] 2021 Dec; Vol. 233, pp. 108879. Date of Electronic Publication: 2021 Nov 16.
Publication Year :
2021

Abstract

COVID-19 is a pandemic requiring immediate solution for treatment because of its complex pathophysiology. Exploration of novel targets and thus treatment will be life savers which is the need of the hour. 2 host factors- TMPRSS2 and ACE2 are responsible for the way the virus will enter and replicate in the host. Also NRF2 is an important protein responsible for its anti-inflammatory role by multiple mechanisms of action like inhibition of NF-kB, suppression of pro-inflammatory genes, etc. NRF2 is deacetylated by Sirtuins and therefore both have a direct association. Absence of SIRT indicates inhibition of NRF2 expression and thus no anti-oxidative and anti-inflammatory protection for the cell. Therefore, we propose that NRF2 activators and/or SIRT activators can be evaluated to check their efficacy in ameliorating the symptoms of COVID-19.<br /> (Copyright © 2021. Published by Elsevier Inc.)

Details

Language :
English
ISSN :
1521-7035
Volume :
233
Database :
MEDLINE
Journal :
Clinical immunology (Orlando, Fla.)
Publication Type :
Academic Journal
Accession number :
34798239
Full Text :
https://doi.org/10.1016/j.clim.2021.108879